Singapore, March 6, 2008: In support of strategies to expand the market share for the antibiotic formulation products in Chinese market, Dragon Pharmaceutical, headquartered in Vancouver, Canada has announced the appointment of Mr. Yimin Guo as the Vice President of Sales and Marketing for Shanxi Weiqida Pharmaceutical, a wholly-owned subsidiary of Dragon Pharma. Mr. Guo will oversee all sales and marketing activities in both Chinese and international markets.

 

Mr. Guo has over 20 years of extensive sales and marketing experience and expertise in antibiotic drugs industry in China. Prior to joining Dragon, Mr. Guo served as the Sales Director at Harbin Pharmaceutical Group, the largest producer of antibiotic drugs in China.

 

Mr. Yanlin Han, Chairman and CEO, Dragon Pharmaceuticals said, "Yimin's expertise in sales and marketing, coupled with his depth of knowledge in the Chinese antibiotic industry, will be invaluable to Dragon and will further bolster our strong sales and marketing division. Dragon is experiencing rapid growth and we are pursuing the goal of becoming a leading vertically integrated antibiotic drugs manufacturer. We believe that Yimin will be a strong addition to our leadership team as Dragon continues to execute growth strategies and create value for shareholders."